The members of the MSU College Republicans and College Democrats were having a battle of vanity, and they were determined to have a winner. The large lecture hall was half full of spectators for ...

Eli Lilly shares jumped 15% after a clinical trial of its experimental pill showed it helped patients with Type 2 diabetes lose weight at levels comparable to leading injectable medications like ...

lifted by Eli Lilly and Apple, as investors weighed progress in U.S. trade negotiations with Japan against concerns about the interest rate outlook. Traders leaned toward optimism following U.S ...

Shares in pharmaceuticals firm Eli Lilly (LLY) ballooned higher today after revealing its new needle-free weight loss drug had performed strongly in trials. Discover outperforming stocks and ...

Eli Lilly on Thursday said its daily obesity pill met the company's goals in the first of several late-stage trials, helping patients with Type 2 diabetes lower their blood sugar and body weight ...

TOKYO -- U.S. drugmaker Eli Lilly has released its Zepbound obesity medication in Japan, targeting the millions said to suffer from the "hidden" scourge of buildups of visceral fat. "We believe ...

Eli Lilly said clinical results of its GLP-1 ... so it must be taken in large doses and is not as effective as the injectables because most of it is digested. But for patients with diabetes ...

Russell Brand's planned lecture on the dangers of 'cancel culture ... But he had still been due to appear at the New College of Florida on a panel about free speech and cancel culture.

For too long, many universities have relied on large lecture halls, theoretical coursework, and outdated curricula that struggle to keep pace with technological developments and industry needs.